ArticlemedRxiv : the preprint server for health sciences2025

Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response After Adjuvant Treatment with Immune Checkpoint Inhibition (ICI) in Patients with Newly Diagnosed Glioblastoma or Gliosarcoma.

Neuro-Oncology Clinical Research Program et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.